SARS-CoV-2 rebound with and without antivirals

Lancet Infect Dis. 2023 Jun;23(6):637-639. doi: 10.1016/S1473-3099(23)00063-4. Epub 2023 Feb 13.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antiviral Agents / pharmacology
  • Antiviral Agents / therapeutic use
  • COVID-19*
  • Dermatologic Agents*
  • Humans
  • SARS-CoV-2
  • Virus Replication

Substances

  • Antiviral Agents
  • Dermatologic Agents